Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service

"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS

Ergebnis verändern

einschränken: Volltextzugriff; Academic (peer-reviewed) journals
erweitern: Auch Volltexte der Artikel durchsuchen; Verwandte Themen suchen

Publikationstyp

Thema

erschienen in

Verlag

Geographic terms

Sprache

Datenbank

mehr ...

Erscheinungsjahr

Von:

Bis:

Treffer 1 - 25 von 901, Suchdauer: 0.77s

12 3 4 5 6 7 8 9 10 11 weiter »

1
The use of lipid-lowering therapy and effects of antihyperglycaemic therapy on lipids in subjects with type 2 diabetes with or without cardiovascular disease: a pooled analysis of data from eleven randomized trials with insulin glargine 100 U/mL

von Markolf Hanefeld ; Louise Traylor ; Ling Gao ; et al.

Cardiovascular Diabetology, Vol 16, Iss 1, Pp 1-9 (2017)

Schlagworte: Type 2 diabetes; Cardiovascular disease; Lipid control; Statins; Clinical trials; Diseases of the circulatory (Cardiovascular) system; RC666-701
- View full text via DOI
Merkliste

2
Remission of type 2 diabetes and pleiotropic effects of long-term testosterone treatment for 'late-onset' hypogonadism: A case report

von Ahmad Haider ; Karim Haider ; Farid Saad ; et al.

SAGE Open Medical Case Reports, Vol 7 (2019)

Schlagworte: Medicine (General); R5-920
- View full text via DOI
Merkliste

3
Sudomotor Testing of Diabetes Polyneuropathy

von Sarah-Maria Krieger ; Manja Reimann ; Rocco Haase ; et al.

Frontiers in Neurology, Vol 9 (2018)

Schlagworte: diabetes; polyneuropathy; screening tool; sudomotor function; Sudoscan; Neurology. Diseases of the nervous system; RC346-429
- View full text via DOI
Merkliste

4
The Current and Potential Therapeutic Use of Metformin—The Good Old Drug

von Józef Drzewoski ; Markolf Hanefeld

Pharmaceuticals, Vol 14, Iss 2, p 122 (2021)

Schlagworte: metformin; pleiotropic effect; oxidative stress; inflammation; cardioprotection; nephroprotection; Medicine; Pharmacy and materia medica; RS1-441
- View full text via DOI
Merkliste

5
Intra-individual variability and circadian rhythm of vascular endothelial growth factors in subjects with normal glucose tolerance and type 2 diabetes.

von Markolf Hanefeld ; Katrin Engelmann ; Dieter Appelt ; et al.

PLoS ONE, Vol 12, Iss 10, p e0184234 (2017)

Schlagworte: Medicine; Science
- View full text via DOI
Merkliste

6
Differential white blood cell count and type 2 diabetes: systematic review and meta-analysis of cross-sectional and prospective studies.

von Effrossyni Gkrania-Klotsas ; Zheng Ye ; Andrew J Cooper ; et al.

PLoS ONE, Vol 5, Iss 10, p e13405 (2010)

Schlagworte: Medicine; Science
- View full text via DOI
Merkliste

7
Identification of the UBP1 locus as a critical blood pressure determinant using a combination of mouse and human genetics.

von Hana Koutnikova ; Markku Laakso ; Lu Lu ; et al.

PLoS Genetics, Vol 5, Iss 8, p e1000591 (2009)

Schlagworte: Genetics; QH426-470
- View full text via DOI
Merkliste

8
Erectile function in men with type 2 diabetes treated with dulaglutide: an exploratory analysis of the REWIND placebo-controlled randomised trial

von Bajaj, Harpreet S ; Gerstein, Hertzel C ; Rao-Melacini, Purnima ; et al.

In The Lancet Diabetes & Endocrinology August 2021 9(8):484-490
- View full text via DOI
Merkliste

9
The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial

von Gerstein, Hertzel C ; Hart, Robert ; Colhoun, Helen M ; et al.

In The Lancet Diabetes & Endocrinology February 2020 8(2):106-114
- View full text via DOI
Merkliste

10
The Metabolic Syndrome and Cancer

von Pistrosch, Frank ; Hanefeld, Markolf ; Beck-Nielsen, Henning, editor

The Metabolic Syndrome : Pharmacology and Clinical Aspects. :55-61
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

11
Decreasing Postprandial Plasma Glucose Using an α-Glucosidase Inhibitor in Subjects with IGT for the Prevention of Type 2 Diabetes Mellitus: The STOP-NIDDM Trial

von Chiasson, Jean-Louis ; Laakso, Markku ; Hanefeld, Markolf ; et al.

Prevention of Type 2 Diabetes : From Science to Therapy. :167-187
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

12
The Role of Alpha-Glucosidase Inhibitors (Acarbose)

von Hanefeld, Markolf ; Schaper, Frank ; Mogensen, Carl Erik, editor

Pharmacotherapy of Diabetes: New Developments : Improving Life and Prognosis for Diabetic Patients. :143-152
- View full text via DOI
Merkliste

13
Beneficial effects of once-daily lixisenatide on overall and postprandial glycemic levels without significant excess of hypoglycemia in Type 2 diabetes inadequately controlled on a sulfonylurea with or without metformin (GetGoal-S)

von Rosenstock, Julio ; Hanefeld, Markolf ; Shamanna, Paramesh ; et al.

In Journal of Diabetes and Its Complications May-June 2014 28(3):386-392
- View full text via DOI
Merkliste

14
A new HPLC-based assay for the measurement of fructosamine-3-kinase (FN3K) and FN3K-related protein activity in human erythrocytes

von Hellwig, Anne ; Scherber, Anja ; Koehler, Carsta ; et al.

Clinical Chemistry and Laboratory Medicine (CCLM). 52(1):93-101
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

15
Störungen des Lipid- und Lipoproteinstoffwechsels

von Julius, Ulrich ; Pietzsch, Jens ; Hanefeld, Markolf ; et al.

Monogen bedingte Erbkrankheiten 1. 6:334-365
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

16
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

von Home, Philip D ; Pocock, Stuart J ; Beck-Nielsen, Henning ; et al.

In The Lancet 20-26 June 2009 373(9681):2125-2135
- View full text via DOI
Merkliste

17
The Effect of Darapladib on Plasma Lipoprotein-Associated Phospholipase A2 Activity and Cardiovascular Biomarkers in Patients With Stable Coronary Heart Disease or Coronary Heart Disease Risk Equivalent: The Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

von Mohler, Emile R., III ; Ballantyne, Christie M. ; Davidson, Michael H. ; et al.

In Journal of the American College of Cardiology 29 April 2008 51(17):1632-1641
- View full text via DOI
Merkliste

18
Effects of pioglitazone and/or simvastatin on low density lipoprotein subfractions in non-diabetic patients with high cardiovascular risk: A sub-analysis from the PIOSTAT study

von Leonhardt, Wolfgang ; Pfützner, Andreas ; Müller, Jürgen ; et al.

In Atherosclerosis 2008 201(1):155-162
- View full text via DOI
Merkliste

19
Anti-Inflammatory Effects of Pioglitazone and/or Simvastatin in High Cardiovascular Risk Patients With Elevated High Sensitivity C-Reactive Protein: The PIOSTAT Study

von Hanefeld, Markolf ; Marx, Nikolaus ; Pfützner, Andreas ; et al.

In Journal of the American College of Cardiology 23 January 2007 49(3):290-297
- View full text via DOI
Merkliste

20
A one-year study comparing the efficacy and safety of rosiglitazone and glibenclamide in the treatment of type 2 diabetes

von Hanefeld, Markolf ; Patwardhan, Rita ; Jones, Nigel P.

In Nutrition, Metabolism and Cardiovascular Diseases 2007 17(1):13-23
- View full text via DOI
Merkliste

21
Relationship Between Diurnal Blood Pressure Variation and Diurnal Blood Glucose Levels in Type 2 Diabetic Patients

von Pistrosch, Frank ; Reissmann, Eva ; Wildbrett, Jan ; et al.

In American Journal of Hypertension 2007 20(5):541-545
- View full text via DOI
Merkliste

22
Effect of simvastatin and/or pioglitazone on insulin resistance, insulin secretion, adiponectin, and proinsulin levels in nondiabetic patients at cardiovascular risk—the PIOSTAT Study

von Forst, Thomas ; Pfützner, Andreas ; Lübben, Georg ; et al.

In Metabolism 2007 56(4):491-496
- View full text via DOI
Merkliste

23
Prandial hyperglycemia: Is it important to track and treat?

von Markolf, Hanefeld ; Frank, Schaper

Current Diabetes Reports. September 2005 5(5):333-339
- Zum Volltext (via ReDI)
Merkliste

24
Novel Insights into the Management of Patients with Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: Baseline Findings from the PERI-DYS Study

von Laufs, Ulrich ; Birkenfeld, Andreas L. ; Fraass, Uwe ; et al.

Cardiovascular Drugs and Therapy. 38(1):119-129
- Zum Volltext (via ReDI)
Merkliste

25
Rivaroxaban compared with low-dose aspirin in individuals with type 2 diabetes and high cardiovascular risk: a randomised trial to assess effects on endothelial function, platelet activation and vascular biomarkers

von Pistrosch, Frank ; Matschke, Jan B. ; Schipp, Dorothea ; et al.

Diabetologia: Clinical, Translational and Experimental Diabetes and Metabolism. :1-12
- Zum Volltext (via ReDI)
Merkliste

12 3 4 5 6 7 8 9 10 11 weiter »

Sie haben nicht gefunden, wonach Sie gesucht haben? Diese Services können Ihnen weiterhelfen.
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag